Procter & Gambl...
Health Care: Health Services
Covance Inc. (CVD: NYSE)
$76.69 0.17 | 0.22%
05/24/13 - 02:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 76.52 |
| 52 Week High | 78.36 |
| 52 Week Low | 44.92 |
| Avg. Daily Vol. (Mil) | 0.39 |
| Beta (3 year) | 1.02 |
| Share Related Items | |
| Mkt Cap (Mil) | 4,275.95 |
| Shares Out (Mil) | 55.88 |
| Float (Mil) | 48.23 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.10 |
| Current Ratio | 1.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.24 |
| Valuation Ratios | |
| Price Earnings | 39.60 |
| Price/Sales | 1.76 |
| Price/Book | 3.18 |
| Price/Cash Flow | 18.70 |
| Per Share Data | |
| Earnings | 1.93 |
| Sales | 43.42 |
| Book Value | 24.03 |
| Cash Flow | 4.10 |
| Business Summary | |
|---|---|
| Covance, Inc is a drug development services company, which provides an array of early-stage and late-stage product development services on a worldwide basis mainly to the pharmaceutical, biotechnology and medical device industries. | |
| General Information | |
| 210 Carnegie Center
Princeton, NJ 08540 |
|
| www.covance.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 11160 | |
| CEO: Joseph L. Herring | |
| Short Interest | |
| Current Month (Mil) | 2.11 |
| Previous Month (Mil) | 2.20 |
| Short Interest Ratio (Days) | 5.70 |
| Management Effectiveness | |
| Return on Equity | 8.00 |
| Return on Assets | 4.80 |
| Return on Investments | 8.00 |
| Profitability | |
| Gross Margin | 33.80 |
| EBIT Margin | 5.30 |
| Profit Margin | 4.40 |
Portfolios with CVD
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHedge Funds' Favorite Stock...
- Contributor8 Health Care Buys Ahead of...
- ContributorBarron's Insider Purchases ...
- ContributorDebt Free Short Squeeze Opp...
- UserPART 6 JPMorgan 28th Annual...
- UserPat711
- UserStockpickrOne
- UserMMB
- ContributorBarron's Summary 2-28-2009
Latest CVD Headlines from TheStreet
- 5 Health Care Stocks Ready to Break Out 04.09.13 | 11:04 am
- Covance Stock Hits New 52-Week High (CVD) 03.27.13 | 11:03 am
- Covance Stock Hits New 52-Week High (CVD) 03.20.13 | 09:03 am
- Covance Inc. (CVD): Today's Featured Health Services Winner 03.18.13 | 05:03 pm
- Covance Reaches New 52-Week High (CVD) 03.12.13 | 03:03 pm
- 5 Stocks Hedge Funds Love -- and So Should You 02.06.13 | 11:02 am
- TheStreet Ratings Top 10 Rating Changes 12.10.12 | 03:12 pm
- Covance Inc. Stock Upgraded (CVD) 12.06.12 | 04:12 am
- Covance Inc. Stock Downgraded (CVD) 08.01.12 | 05:08 am
- Covance Management Discusses Q2 2012 Results - Earnings Call Transcript 07.26.12 | 09:07 pm
Press Releases for CVD
- Covance Expands Singapore Central Laboratory By 50 Percent To Meet Clients' Increased Asia Pacific Focus - PR Newswire 04.16.13 | 01:04 am
- Covance To Present At The Citi 2013 Global Healthcare Conference - PR Newswire 02.22.13 | 04:02 pm
- Covance To Present At The Leerink Swann Global Healthcare Conference - PR Newswire 02.11.13 | 12:02 pm
- Covance To Present At The 31st Annual J. P. Morgan Healthcare Conference - PR Newswire 01.07.13 | 10:01 am
- Covance Receives SFDA GLP Certification For Its Early Development Facility In Shanghai, China - PR Newswire 12.03.12 | 05:12 pm
- Covance Earns CEO Cancer Gold Standard Employer Accreditation - PR Newswire 12.03.12 | 09:12 am
- Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - PR Newswire 11.12.12 | 10:11 am
- Covance And NAFC Sponsor Free Medical Clinic For More Than 1,200 Patients In Dallas, Texas - PR Newswire 10.16.12 | 08:10 am
- Covance To Present At The Morgan Stanley Global Healthcare Conference - PR Newswire 09.07.12 | 05:09 pm
- Covance Appoints Dr. Steve Street To Lead Worldwide Safety Assessment And Pharmaceutical Chemistry Services - PR Newswire 06.18.12 | 08:06 am
Partner Headlines for CVD
- Long-Term Deals With Drug Makers Help Icon's Earnings - Investor's Business Daily 03.06.13 | 02:03 pm
- Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB) - Benzinga 11.24.12 | 05:11 pm
- Parexel Signs ASR Agreement - Analyst Blog - NASDAQ 09.21.12 | 03:09 pm
- Apple to REPORT Earnings and 1 Stock Analysis to Note - Wall St. Cheat Sheet 07.24.12 | 01:07 pm
- Covance's EPS Meets, Misses on Revs - Analyst Blog - Zacks 05.04.12 | 05:05 pm
- Covance Beats Zacks Estimates - Analyst Blog - Zacks 11.04.11 | 05:11 pm
- Contract Research (CROs): On the Brink of Recovery - Seeking Alpha 04.15.11 | 07:04 am
- Covance in Tune with Zacks Est. - Analyst Blog - Zacks 01.27.11 | 10:01 am
- Zacks Bull and Bear of the Day Highlights: Skyworks Solutions, Universal Forest Products, Sanofi-Aventis, Covance and Jack in the Box - Press Releases - Zacks 10.01.10 | 08:10 am
- UPDATE 1-Covance wins up to $2.2 bln Sanofi R&D contract - Reuters 09.30.10 | 05:09 am
